Integrated digital error suppression for improved detection of circulating tumor DNA AM Newman, AF Lovejoy, DM Klass, DM Kurtz, JJ Chabon, F Scherer, ... Nature biotechnology 34 (5), 547-555, 2016 | 1055 | 2016 |
Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling AA Chaudhuri, JJ Chabon, AF Lovejoy, AM Newman, H Stehr, TD Azad, ... Cancer discovery 7 (12), 1394-1403, 2017 | 784 | 2017 |
Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients JJ Chabon, AD Simmons, AF Lovejoy, MS Esfahani, AM Newman, ... Nature communications 7 (1), 1-15, 2016 | 614 | 2016 |
Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients JJ Chabon, AD Simmons, AF Lovejoy, MS Esfahani, AM Newman, ... Nature communications 7 (1), 1-15, 2016 | 614 | 2016 |
Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers CM Blakely, TBK Watkins, W Wu, B Gini, JJ Chabon, CE McCoach, ... Nature genetics 49 (12), 1693-1704, 2017 | 484 | 2017 |
Integrating genomic features for non-invasive early lung cancer detection JJ Chabon, EG Hamilton, DM Kurtz, MS Esfahani, EJ Moding, H Stehr, ... Nature 580 (7802), 245-251, 2020 | 458 | 2020 |
Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA F Scherer, DM Kurtz, AM Newman, H Stehr, AFM Craig, MS Esfahani, ... Science translational medicine 8 (364), 364ra155-364ra155, 2016 | 432 | 2016 |
Circulating tumor DNA measurements as early outcome predictors in diffuse large B-cell lymphoma DM Kurtz, F Scherer, MC Jin, J Soo, AFM Craig, MS Esfahani, JJ Chabon, ... Journal of Clinical Oncology 36 (28), 2845, 2018 | 387 | 2018 |
Noninvasive early identification of therapeutic benefit from immune checkpoint inhibition BY Nabet, MS Esfahani, EJ Moding, EG Hamilton, JJ Chabon, H Rizvi, ... Cell 183 (2), 363-376. e13, 2020 | 251 | 2020 |
Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancer EJ Moding, Y Liu, BY Nabet, JJ Chabon, AA Chaudhuri, AB Hui, ... Nature Cancer 1 (2), 176-183, 2020 | 238 | 2020 |
Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA DM Kurtz, J Soo, L Co Ting Keh, S Alig, JJ Chabon, BJ Sworder, A Schultz, ... Nature biotechnology 39 (12), 1537-1547, 2021 | 179 | 2021 |
Circulating tumor DNA analysis for detection of minimal residual disease after chemoradiotherapy for localized esophageal cancer TD Azad, AA Chaudhuri, P Fang, Y Qiao, MS Esfahani, JJ Chabon, ... Gastroenterology 158 (3), 494-505. e6, 2020 | 171 | 2020 |
Detection and surveillance of bladder cancer using urine tumor DNA JC Dudley, J Schroers-Martin, DV Lazzareschi, WY Shi, SB Chen, ... Cancer discovery 9 (4), 500-509, 2019 | 159 | 2019 |
Antagonistic regulation by the transcription factors C/EBPα and MITF specifies basophil and mast cell fates X Qi, J Hong, L Chaves, Y Zhuang, Y Chen, D Wang, J Chabon, ... Immunity 39 (1), 97-110, 2013 | 159 | 2013 |
A mathematical model of ctDNA shedding predicts tumor detection size S Avanzini, DM Kurtz, JJ Chabon, EJ Moding, SS Hori, SS Gambhir, ... Science advances 6 (50), eabc4308, 2020 | 131 | 2020 |
Molecular profiling of single circulating tumor cells from lung cancer patients S Park, DJ Wong, CC Ooi, DM Kurtz, O Vermesh, A Aalipour, S Suh, ... Proceedings of the National Academy of Sciences 113 (52), E8379-E8386, 2016 | 114 | 2016 |
Transforming Growth Factor-β Signaling Promotes Pulmonary Hypertension Caused by Schistosoma Mansoni BB Graham, J Chabon, L Gebreab, J Poole, E Debella, L Davis, T Tanaka, ... Circulation 128 (12), 1354-1364, 2013 | 108 | 2013 |
KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition MS Binkley, YJ Jeon, M Nesselbush, EJ Moding, BY Nabet, D Almanza, ... Cancer discovery 10 (12), 1826-1841, 2020 | 100 | 2020 |
Circulating tumor DNA analysis to assess risk of progression after long-term response to PD-(L) 1 blockade in NSCLC MD Hellmann, BY Nabet, H Rizvi, AA Chaudhuri, DK Wells, MPS Dunphy, ... Clinical Cancer Research 26 (12), 2849-2858, 2020 | 94 | 2020 |
Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling. Cancer Discov. 2017; 7: 1394–1403. doi: 10.1158/2159-8290 AA Chaudhuri, JJ Chabon, AF Lovejoy, AM Newman, H Stehr, TD Azad, ... CD-17-0716.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 94 | |